Lung cancer is the leading cause of cancer death for both men and women in the United States. According to the American Cancer Society, more than 225,000 Americans will be diagnosed with lung cancer. At the Rush-Riverside Cancer Institute our goal is to improve the survival rate and quality of life for our patients diagnosed with lung cancer. Our comprehensive, multidisciplinary approach is comprised of a team including physicians, medical oncologists, radiation oncologists, surgeons, pulmonologists, radiologists and a designated Imaging Patient Navigator.
Meet Our Team of Experts
Our dedicated team of experts work together to personalize each patient’s journey, every step of the way.
Learn more about each specialty below.
Signs, Symptoms and Risk Factors of Lung Cancer
Lung cancer usually does not cause symptoms when it first develops, but symptoms often become present after the tumor begins growing. A cough is the most common symptom of lung cancer. For more information please read out our list of Lung Cancer Signs and Symptoms.
Lung Cancer Screenings and Diagnosis
Most lung cancers are discovered at late stages, when treatment is more difficult. Lung Cancer screening allows the diagnosis of lung cancer at its earliest and most treatable stages. Lung cancer screening can prolong life by detecting disease early, when it is potentially more treatable.
- Learn more about Riverside's Comprehensive Lung Cancer Screening
Comprehensive Treatment of Lung Cancer
At the Rush-Riverside Cancer Institute your specific treatment for lung cancer will be personalized by your doctor based on several aspects including: your age, overall health, medical history and type of cancer. Learn more about the Lung Cancer Treatment Options available at the Rush-Riverside Cancer Institute.
About Riverside’s Lung Cancer Screening Program
The Lung Cancer Screening Program at Riverside Medical Center was initiated in 2013 based on data from the community indicating the need to initiate a formalized screening program targeting smokers in our community. Each current smoker is given information regarding smoking cessation.
A notable trend has shown an increase in smoking cessation among program participants. At the time of first follow up in 2014, 2% of smokers had quit; in 2015, 7% had quit. In 2016, the program was reviewed by the Cancer Committee and sanctioned and formalized as the annual screening program. Year to date, 8% of lung cancer screening patients have quit smoking.
The resources dedicated toward this program are proven effective. Patients are making a behavioral change and choosing to be tobacco free and thereby reducing their risk of developing lung disease.
|Lung Cancer Screening Program and smoking status among participants|
|New Screenings||2013||2014||2015||2016||Overall To Date|
|% of Current Smokers||55%||49%||63%||62%||57%|
|Followup Screenings||2013||2014||2015||2016||Overall To Date|
|% of Current Smokers||52%||36%||47%||43%|
|% of Patients Who Quite Smoking||2%||7%||8%||7%|
|Overall % of Current Smokers Screened||49%||54%||53%||53%|
Rush-Riverside Cancer Institute
375 N. Wall St.
Kankakee, IL 60901
Rush-Riverside Cancer Institute
Betty Burch Bridgewater Center for Radiation Therapy
200 Riverside Drive
Bourbonnais, IL 60914